Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy
Author(s) -
Tatsuhiko Sato,
Shinichi Morita,
Hajime Bando,
Shigeru Sato,
Toshihide Ikeda,
Kazuyuki Emi
Publication year - 2013
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.106387
Subject(s) - medicine , vitrectomy , bevacizumab , vitreous hemorrhage , diabetic retinopathy , ophthalmology , visual acuity , incidence (geometry) , surgery , retinal detachment , retinal , diabetes mellitus , chemotherapy , physics , optics , endocrinology
To evaluate the effect of preoperative intravitreal bevacizumab (IVB) on surgical procedures, visual prognosis, and postoperative complications, especially postoperative vitreous hemorrhage, in cases with proliferative diabetic retinopathy (PDR).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom